Viewing Study NCT05841160


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-28 @ 5:11 PM
Study NCT ID: NCT05841160
Status: COMPLETED
Last Update Posted: 2023-06-09
First Post: 2023-04-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
Sponsor: Emalex Biosciences Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EBS-101-HV-105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None UNKNOWN View